Co-morbid Polycystic Ovarian Syndrome with Idiopathic Intracranial Hypertension
dc.contributor.author | Thaller, Mark | |
dc.contributor.author | Adderley, Nicola J | |
dc.contributor.author | Subramanian, Anuradhaa | |
dc.contributor.author | Mollan, Susan P | |
dc.contributor.author | Sinclair, Alexandra J | |
dc.date.accessioned | 2024-02-14T14:03:22Z | |
dc.date.available | 2024-02-14T14:03:22Z | |
dc.date.issued | 2023-01-10 | |
dc.identifier.citation | Thaller M, Adderley NJ, Subramanian A, Mollan SP, Sinclair AJ. Co-morbid Polycystic Ovarian Syndrome with Idiopathic Intracranial Hypertension. Neuroophthalmology. 2023 Jan 10;47(1):49-52. doi: 10.1080/01658107.2022.2162089 | en_US |
dc.identifier.issn | 0165-8107 | |
dc.identifier.eissn | 1744-506X | |
dc.identifier.doi | 10.1080/01658107.2022.2162089 | |
dc.identifier.pmid | 36798860 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14200/3669 | |
dc.description.abstract | The link between polycystic ovarian syndrome (PCOS) and idiopathic intracranial hypertension (IIH) has long been debated. Historically, there is a wide range of reported occurrence of both conditions, being between 15% and 64%. Both conditions share a common phenotype. The awareness that in a new large data study that there is a 1.5-fold increased prevalence of diagnosed PCOS in participants with IIH as compared to the controls is important. Assessment for the potential of co-morbid PCOS in women with IIH is important as this may enable optimisation of weight and fertility management. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor and Francis Group | en_US |
dc.relation.url | http://www.tandfonline.com/loi/ioph20 | en_US |
dc.rights | © 2023 Taylor & Francis Group, LLC. | |
dc.subject | Gynaecology | en_US |
dc.subject | Endocrinology | en_US |
dc.subject | Neurology | en_US |
dc.title | Co-morbid Polycystic Ovarian Syndrome with Idiopathic Intracranial Hypertension | en_US |
dc.type | Article | |
dc.source.journaltitle | Neuro-Ophthalmology | |
dc.source.volume | 47 | |
dc.source.issue | 1 | |
dc.source.beginpage | 49 | |
dc.source.endpage | 52 | |
dc.source.country | United Kingdom | |
dc.source.country | England | |
rioxxterms.version | NA | en_US |
dc.contributor.trustauthor | Thaller, Mark | |
dc.contributor.trustauthor | Mollan, Susan | |
dc.contributor.department | Neurology | en_US |
dc.contributor.department | Opthalmology | en_US |
dc.contributor.role | Medical and Dental | en_US |
oa.grant.openaccess | na | en_US |